To Evaluate and Compare the Microleakage of Chitosan Nano Hydrogel-Incorporated MTA and Glass Ionomer Cements When used as a Retrograde Filling Material

Background: An inadequate apical seal stands out as a primary cause of disappointment in surgical endodontic procedures. Therefore, the choice of root-end filling material should aim to prevent the leakage of potential contaminants into the periapical tissue. Aim: To evaluate and compare microleakag...

Full description

Saved in:
Bibliographic Details
Main Authors: Vinaykumar G. Suryavanshi, Ravi K. Tale, Vivekanand D. Kolvekar, Rashmi Chordiya, P S Amal, B Abijeet
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
Online Access:https://journals.lww.com/10.4103/jpbs.jpbs_747_24
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: An inadequate apical seal stands out as a primary cause of disappointment in surgical endodontic procedures. Therefore, the choice of root-end filling material should aim to prevent the leakage of potential contaminants into the periapical tissue. Aim: To evaluate and compare microleakage of chitosan nano hydrogel-incorporated mineral trioxide aggregate (MTA) and glass ionomer cement (GIC) when used as a retrograde filling material. Materials and Methods: Sixty single-rooted premolars were decoronated at cemento enamel junction (CEJ), and root canals were prepared and obturated, with the coronal part sealed with a composite. The dye absorption was measured by an automatic spectrophotometer. Results: The results showed that the MTA + chitosan group had less microleakage values compared to the MTA group but was not statistically significant and GIC + chitosan had less microleakage values compared to the GIC group and was statistically significant. Conclusion: Chitosan-incorporated MTA and chitosan-incorporated GIC can be considered as retrograde filling material; however, further in vitro and in vivo research and long-term clinical studies are required.
ISSN:0976-4879
0975-7406